Yun Fan

Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphoma

Yue Shi, Mei Dong, Xiaoting Hong et al. · Annals of Oncology · 2015 · 384 citations

Lymphoid Neoplasia, Medicine, Immunology +7

Pyrotinib in <i>HER2</i>-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study

Caicun Zhou, Xingya Li, Qiming Wang et al. · Journal of Clinical Oncology · 2020 · 197 citations

Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial

Yunpeng Yang, Jianya Zhou, Jianying Zhou et al. · The Lancet Respiratory Medicine · 2019 · 135 citations

Biomarker Analysis, Medicine, Pharmacology +8

Efficient CRISPR-Cas9 Gene Disruption System in Edible-Medicinal Mushroom Cordyceps militaris

Bai‐Xiong Chen, Tao Wei, Zhiwei Ye et al. · Frontiers in Microbiology · 2018 · 122 citations · Full text

Tislelizumab Plus Platinum and Etoposide Versus Placebo Plus Platinum and Etoposide as First-Line Treatment for Extensive-Stage SCLC (RATIONALE-312): A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 3 Clinical Trial

Ying Cheng, Yun Fan, Yanqiu Zhao et al. · Journal of Thoracic Oncology · 2024 · 104 citations · Full text

Phase 3, Clinical Therapeutic, Pharmacology +7